» Articles » PMID: 30952382

Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model)

Abstract

Clinical risk stratification for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HC) employs rules derived from American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines or the HCM Risk-SCD model (C-index ∼0.69), which utilize a few clinical variables. We assessed whether data-driven machine learning methods that consider a wider range of variables can effectively identify HC patients with ventricular arrhythmias (VAr) that lead to SCD. We scanned the electronic health records of 711 HC patients for sustained ventricular tachycardia or ventricular fibrillation. Patients with ventricular tachycardia or ventricular fibrillation (n = 61) were tagged as VAr cases and the remaining (n = 650) as non-VAr. The 2-sample ttest and information gain criterion were used to identify the most informative clinical variables that distinguish VAr from non-VAr; patient records were reduced to include only these variables. Data imbalance stemming from low number of VAr cases was addressed by applying a combination of over- and undersampling strategies. We trained and tested multiple classifiers under this sampling approach, showing effective classification. We evaluated 93 clinical variables, of which 22 proved predictive of VAr. The ensemble of logistic regression and naïve Bayes classifiers, trained based on these 22 variables and corrected for data imbalance, was most effective in separating VAr from non-VAr cases (sensitivity = 0.73, specificity = 0.76, C-index = 0.83). Our method (HCM-VAr-Risk Model) identified 12 new predictors of VAr, in addition to 10 established SCD predictors. In conclusion, this is the first application of machine learning for identifying HC patients with VAr, using clinical attributes. Our model demonstrates good performance (C-index) compared with currently employed SCD prediction algorithms, while addressing imbalance inherent in clinical data.

Citing Articles

New Innovations to Address Sudden Cardiac Arrest.

Shen C, Bhavnani S, Rogers J US Cardiol. 2024; 18:e09.

PMID: 39494400 PMC: 11526475. DOI: 10.15420/usc.2023.25.


Evaluating Social Determinants of Health Variables in Advanced Analytic and Artificial Intelligence Models for Cardiovascular Disease Risk and Outcomes: A Targeted Review.

Snowdon J, Scheufele E, Pritts J, Le P, Mensah G, Zhang X Ethn Dis. 2024; 33(1):33-43.

PMID: 38846264 PMC: 11152155. DOI: 10.18865/1704.


Artificial Intelligence-Based Clinical Decision Support Systems in Cardiovascular Diseases.

Bozyel S, Simsek E, Burunkaya D, Guler A, Korkmaz Y, Seker M Anatol J Cardiol. 2024; .

PMID: 38168009 PMC: 10837676. DOI: 10.14744/AnatolJCardiol.2023.3685.


Model for classification of heart failure severity in patients with hypertrophic cardiomyopathy using a deep neural network algorithm with a 12-lead electrocardiogram.

Togo S, Sugiura Y, Suzuki S, Ohno K, Akita K, Suwa K Open Heart. 2023; 10(2).

PMID: 38056911 PMC: 10711906. DOI: 10.1136/openhrt-2023-002414.


Virtual healthcare solutions in heart failure: a literature review.

Lee K, Breznen B, Ukhova A, Martin S, Koehler F Front Cardiovasc Med. 2023; 10:1231000.

PMID: 37745104 PMC: 10513031. DOI: 10.3389/fcvm.2023.1231000.